Bright Health Group - BHG Stock Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bright Health Group in the last year. There are currently 4 sell ratings, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" BHG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BHG, but not buy additional shares or sell existing shares.
View BHG analyst ratings or view top-rated stocks.

8 Wall Street research analysts have issued 12-month target prices for Bright Health Group's stock. Their BHG share price forecasts range from $1.00 to $4.00. On average, they expect the company's stock price to reach $2.52 in the next year. This suggests a possible upside of 155.2% from the stock's current price.
View analysts price targets for BHG or view top-rated stocks among Wall Street analysts.

Bright Health Group's stock was trading at $0.6499 on January 1st, 2023. Since then, BHG shares have increased by 52.1% and is now trading at $0.9883.
View the best growth stocks for 2023 here.

Bright Health Group saw a increase in short interest in December. As of December 30th, there was short interest totaling 10,480,000 shares, an increase of 13.2% from the December 15th total of 9,260,000 shares. Based on an average trading volume of 1,810,000 shares, the days-to-cover ratio is currently 5.8 days. Currently, 15.8% of the company's shares are short sold.
View Bright Health Group's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 1st 2023.
View our BHG earnings forecast.

Bright Health Group, Inc. (NYSE:BHG) announced its quarterly earnings results on Wednesday, November, 9th. The company reported ($0.35) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.40) by $0.05. The firm had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.78 billion. Bright Health Group had a negative trailing twelve-month return on equity of 190.07% and a negative net margin of 26.48%.

Bright Health Group issued an update on its FY 2023 earnings guidance on Tuesday, January, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.40 billion-$3.60 billion, compared to the consensus revenue estimate of $3.09 billion.

(BHG) raised $1.3 billion in an IPO on Thursday, June 24th 2021. The company issued 60,000,000 shares at $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, Morgan Stanley and Barclays served as the underwriters for the IPO and BofA Securities, Citigroup, Piper Sandler, Nomura and RBC Capital Markets were co-managers.

Bright Health Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "BHG."

Shares of BHG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BHG stock can currently be purchased for approximately $0.99.

Bright Health Group (NYSE:BHG) has a market capitalization of $622.33 million and generates $4.03 billion in revenue each year. The company earns $-1,184,860,000.00 in net income (profit) each year or ($2.56) on an earnings per share basis.

The company employs 3,203 workers across the globe.

The official website for the company is www.brighthealthcare.com. The company can be reached via phone at 612-238-1321 or via email at ir@brighthealthgroup.com.